輸入代號或公司名稱後按 Enter
1795

美時

-3.50 (-1.98%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
173.501,269成交張數12.26本益比1.90股價淨值比1.56%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q22.44-12.4%14.316.427.3%2.66%16.86%
2026Q12.15-60.2%14.665.676.6%2.37%17.03%
2025Q44.260.0%17.9111.2217.9%4.88%21.00%
2025Q35.46-7.5%17.9114.3530.1%6.75%22.32%
2025Q22.78-44.6%18.357.2815.3%3.50%25.03%
2025Q15.4038.1%20.5914.3530.3%6.77%28.49%
2024Q44.26182.4%19.1011.3325.7%5.47%26.30%
2024Q35.9025.6%16.3515.6529.9%8.09%23.42%
2024Q25.025.0%15.1413.3228.1%7.47%23.68%
2024Q13.91-13.5%14.9010.3624.7%6.01%25.28%
2023Q41.51142.8%15.524.0011.7%2.34%26.32%
2023Q34.70-40.4%14.6312.4627.2%7.74%25.63%
2023Q24.79288.0%17.8212.6628.5%8.58%35.14%
2023Q14.52166.3%14.2611.9426.4%8.54%29.39%
2022Q40.62-34.4%11.441.685.3%1.23%24.23%
2022Q37.89500.7%11.7720.7938.6%16.76%25.57%
2022Q21.23-8.1%5.193.2811.3%2.86%12.46%
2022Q11.70-7.0%5.304.4614.1%3.94%13.55%
2021Q40.95-26.2%5.432.529.0%2.30%14.17%
2021Q31.3115.7%5.763.4811.4%3.24%15.39%
2021Q21.3410.6%5.593.5510.2%3.59%15.08%
2021Q11.83242.6%5.464.4913.5%5.03%16.09%
2020Q41.284.173.1810.2%3.74%
2020Q31.142.799.7%3.45%
2020Q21.212.9911.2%3.85%
2020Q10.531.326.7%